Literature DB >> 86552

Carcinogenicity of hexachlorocyclohexane (BHC) in pure inbred swiss mice.

S K Kashyap, S K Nigam, R C Gupta, A B Karnik, S K Chatterjee.   

Abstract

Inbred Swiss mice were treated with technical BHC (1) orally with the diet or by intubation and (2) by skin painting. The total duration of the experiment was 80 weeks. There was no difference in body growth and mortality between the experimental and control groups. Symptoms of intoxication in the form of convulsions and tendency of circling in one direction with drooping ears were observed alongwith corneal opacity 40 weeks after the experiment. Oral BHC treatment resulted in a significant increase in the incidence of liver tumours and tumours of lymphoreticular tissue. Males and females were equally susceptible. Skin painting of mice did not significantly increase the incidence of tumour.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 86552     DOI: 10.1080/03601237909372130

Source DB:  PubMed          Journal:  J Environ Sci Health B        ISSN: 0360-1234            Impact factor:   1.990


  4 in total

Review 1.  Pharmacotherapy of ectoparasitic infections.

Authors:  T C Roos; M Alam; S Roos; H F Merk; D R Bickers
Journal:  Drugs       Date:  2001       Impact factor: 9.546

2.  Serum hexachlorocyclohexane residues in workers engaged at a HCH manufacturing plant.

Authors:  S K Nigam; A B Karnik; S K Majumder; K Visweswariah; G S Raju; K M Bai; B C Lakkad; K N Thakore; B B Chatterjee
Journal:  Int Arch Occup Environ Health       Date:  1986       Impact factor: 3.015

3.  Experimental studies on insecticides commonly used in India.

Authors:  S K Nigam; D K Bhatt; A B Karnik; K N Thakore; K Aravinda Babu; B C Lakkad; S K Kashyap; S K Chatterjee
Journal:  J Cancer Res Clin Oncol       Date:  1981       Impact factor: 4.553

4.  Prediagnostic blood levels of organochlorines and risk of non-Hodgkin lymphoma in three prospective cohorts in China and Singapore.

Authors:  Bryan A Bassig; Xiao-Ou Shu; Andreas Sjödin; Woon-Puay Koh; Yu-Tang Gao; Jennifer Adams-Haduch; Mark Davis; Renwei Wang; Yong-Bing Xiang; Lawrence S Engel; Mark P Purdue; Bu-Tian Ji; Gong Yang; Richard S Jones; Hilde Langseth; H Dean Hosgood; Tom K Grimsrud; Wei Jie Seow; Jason Y Y Wong; Wei Hu; Dazhe Chen; Wei Zheng; Jian-Min Yuan; Qing Lan; Nathaniel Rothman
Journal:  Int J Cancer       Date:  2019-05-09       Impact factor: 7.316

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.